Transparency
Market Research (TMR) has published a new report titled, “Extracorporeal
CO2 Removal Market - Global Industry Analysis, Size, Share, Growth, Trends, and
Forecast, 2018–2026”. According to the report, the global
extracorporeal CO2 removal market was
valued at US$ 50.0 Mn in 2017 and is projected to expand at a CAGR of 6.0% from
2018 to 2026. Rise in demand for innovative technologies and adoption of ECCO2R
devices is expected to boost the growth of the global extracorporeal CO2
removal market from 2018 to 2026. North America and Europe are anticipated to
dominate the global market during the forecast period owing to early
availability of novel medical technologies, developed health care
infrastructure, and increased patient awareness. Asia Pacific is expected to
account for significant market share by 2026. This is attributed to large
chronic obstructive pulmonary disease (COPD) and acute respiratory distress
syndrome (ARDS) patient base in developing countries such as China and India.
Rise in adoption of technologically advanced products manufactured by key
manufacturers such as ALung Technologies and Xenios AG is likely to drive the
global ECCO2R market.
Rise
in Demand for Minimally Invasive Ventilation to Drive Market
ECCO2R technique is
widely used to avoid invasive mechanical ventilation, especially in patients
failing non-invasive ventilation. It also has a feasible therapeutic
application to facilitate mechanical ventilation in ARDS patients. ECCO2R can
be a promising adjuvant therapeutic strategy for the management of patients
with severe exacerbations of COPD and to achieve protective or ultra-protective
ventilation in patients with ARDS without life-threatening hypoxemia. Rise in
demand for minimally invasive ventilation is anticipated to propel the
extracorporeal CO2 removal market during the forecast period. Over invasive
mechanical ventilation extracorporeal life support offers safer simpler
respiratory applications with veno-venous support and biocompatible membranes.
Gas
Exchange Units Segment Leads the Market
The report offers
detailed segmentation of the global extracorporeal CO2 removal market based on
product and end-user. In terms of product, the disposables segment is projected
to account for leading share of the global market during the forecast period
from 2018 to 2026. Extracorporeal carbon dioxide removal (ECCO2R) devices
include disposables, which are used per case per patient basis. Gas exchange
units are also called oxygenator/cartridges. These play an important role in
effective CO2 removal. Access cannulas are also integral part of ECCO2R
procedure. Factors attributed to the higher share of the disposables segment of
the global market include high demand for and consumption of disposables in
extracorporeal CO2 removal procedures.
Hospitals
Segment Dominates the Market
The hospitals
segment is projected to account for a significant share of the global
extracorporeal CO2 removal market during the forecast period. The segment is
anticipated to expand at a CAGR 6.0% from 2018 to 2026. Major reason
responsible for the dominance of hospitals segment such as COPD & ARDS are
life threatening diseases that require immediate care. Therefore, increase in
number of hospital visits and rise in prevalence of COPD and ARDS are expected
to boost the hospitals segment during the forecast period. The surgical centers
segment is projected to hold substantial share of the global extracorporeal CO2
removal market during the forecast period. Surgical centers are well-equipped
with sophisticated instruments; hence people in developing and underdeveloped
countries prefer these settings.
Significant
Incremental Opportunity in North America
In terms of revenue,
North America is likely to continue to dominate the global extracorporeal CO2
removal market during the forecast period, owing to early adoption of
technologies and large patient pool of COPD and ARDS. The region is projected
to be the most attractive market for extracorporeal CO2 removal devices, with
high attractiveness index. The market in the region is expected to expand at a
CAGR of 6.0% during the forecast period due to high demand for novel medical
technologies. Increase in prevalence of chronic respiratory diseases and surge
in demand for rapid and safe minimally invasive ventilation devices have
accelerated the growth of the extracorporeal CO2 removal market in North
America.
Highly
Consolidated Market, with Key Players Accounting for Over 50.0% Share
The report also provides
profiles of leading players operating in the global extracorporeal CO2 removal
market. ALung Technologies, Inc., Xenios AG, Estor S.p.A., Medtronic plc,
Medica S.p.A., and Getinge Group are the major players operating in the market.
These players offer products with proprietary technologies, for example ALung
Technologies offers proprietary products such as Hemolung RAS. Several key
companies have recently introduced analytical instruments that can carry out
rapid analysis in near-patient settings. Novalung is core technology platforms
offered by the Xenios AG include blood extracorporeal CO2 machines, artificial
lungs, temperature control, vascular access devices, and biocompatible surface.
More
Trending Reports by Transparency Market Research:
About
Us
Transparency Market
Research is a global market intelligence company, providing global business
information reports and services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insight for thousands
of decision makers. Our experienced team of Analysts, Researchers, and
Consultants, use proprietary data sources and various tools and techniques to
gather, and analyze information.
Our data repository
is continuously updated and revised by a team of research experts, so that it
always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market
Research,
90 Sate Street,
Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
